Surrey Heartlands

Joint Formulary & PAD

Larvae (maggot) therapy - Wound debridement

You are here : Home > Formulary Search > Larvae (maggot) therapy - Wound debridement

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Not Specified
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
R
Restrictions / Comments :
Important
On recommendation of TVN only

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Larvae (maggot) therapy
Indication :
Wound debridement
Group Name :
Keywords :
larve
Brand Names Include :
Larve, biobags, Debridement of chronic and hard to heal wounds, including venous and arterial ulcers
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Larvae (maggot) therapy is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Wound debridement.

  • No records returned.

Committee Recommendations (1)

05 Feb 25 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

This drug has been included on the joint formulary having been agreed by the DTC of at least one Surrey Heartlands Acute Trust.

See “Formulary Status” to identify where this drug has been agreed for use.